Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates

This publication has 120 references indexed in Scilit:

• Analytical and bioanalytical technologies for characterizing antibody–drug conjugates
  Current Opinion in Chemical Biology, 2013
• High-Throughput Method Development for Sensitive, Accurate, and Reproducible Quantification of Therapeutic Monoclonal Antibodies in Tissues Using Orthogonal Array Optimization and Nano Liquid Chromatography/Selected Reaction Monitoring Mass Spectrometry
  Analytical Chemistry, 2012
• A sensitive LC–MS/MS method for the determination of free maytansinoid DM4 concentrations—Method development, validation, and application to the nonclinical studies of antitumor agent DM4 conjugated hu-anti-Cripto MAb B3F6 (B3F6-DM4) in rats and monkeys
  International Journal of Mass Spectrometry, 2012
• Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
  Nature Biotechnology, 2012
• Analytical methods for physicochemical characterization of antibody drug conjugates
  mAbs, 2011
• Charge variants in IgG1
  mAbs, 2010
• A Rapid, Reproducible, On-the-Fly Orthogonal Array Optimization Method for Targeted Protein Quantification by LC/MS and Its Application for Accurate and Sensitive Quantification of Carbonyl Reductases in Human Liver
  Analytical Chemistry, 2010
• Modifying the charge state distribution of proteins in electrospray ionization mass spectrometry by chemical derivatization
  Journal of the American Society for Mass Spectrometry, 2009
• Improved sensitivity for quantification of proteins using triply charged cleavable isotope‐coded affinity tag peptides
  Rapid Communications in Mass Spectrometry, 2005
• Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry
  Protein Science, 2005